Last reviewed · How we verify
modified-DEP — Competitive Intelligence Brief
marketed
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
modified-DEP (modified-DEP) — The First Affiliated Hospital of Soochow University. Modified-DEP is a diethylpyrocarbonate-modified compound that acts as an immunomodulatory agent to enhance immune responses.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| modified-DEP TARGET | modified-DEP | The First Affiliated Hospital of Soochow University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- modified-DEP CI watch — RSS
- modified-DEP CI watch — Atom
- modified-DEP CI watch — JSON
- modified-DEP alone — RSS
Cite this brief
Drug Landscape (2026). modified-DEP — Competitive Intelligence Brief. https://druglandscape.com/ci/modified-dep. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing